StockData
Prenetics Global Ltd logo

Prenetics Global Ltd (PRE) shareholders

PRENasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as PRENW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 10/30
$16.72−0.92 (-5.22%)

Close on Nov 12, 2026Market cap $282.14MP/E –Yield –

Ownership

Who owns Prenetics Global's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
5 buys · 0 sales
Net bought $999.70K

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Danny Sheng Wu YeungChief Executive Officer, Director1,682,207Aug 24, 2026
Hoi Chun LoChief Financial Officer573,648Oct 2, 2026
Thuan Yen TatVP, Finance of IM8 (US) LLC–Sep 4, 2026
Brian J. RosinCFO of IM8 (US) LLC23,100Aug 26, 2026
Hudson Blake LeograndeDirector10,001Nov 5, 2026
Caroline S. LevyDirector–Aug 26, 2026
Yin Pan ChengDirector59,051Jun 16, 2026
David VanderveenDirector46,897Jun 16, 2026
Darshan Ravindra ShahDirector4,506Mar 30, 2026
Capital Management Holdings Ltd M13––Jun 16, 2026
Yeung Ltd Da––Mar 30, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Hudson Blake Leogrande
Director
Nov 4, 2026Option exercise+2,000––10,001
Hudson Blake Leogrande
Director
Oct 4, 2026Option exercise+2,000––8,001
Hoi Chun Lo
Chief Financial Officer
Sep 30, 2026Option exercise+7,635––573,648
Hudson Blake Leogrande
Director
Sep 4, 2026Option exercise+2,000––6,001
Brian J. Rosin
CFO of IM8 (US) LLC
Aug 25, 2026Buy+5,100$22.80$116.28K23,100
Brian J. Rosin
CFO of IM8 (US) LLC
Aug 24, 2026Buy+18,000$21.19$381.42K18,000
Danny Sheng Wu Yeung
Chief Executive Officer, Director
Aug 24, 2026Buy+6,000$20.90$125.40K101,235
Danny Sheng Wu Yeung
Chief Executive Officer, Director
Aug 24, 2026Buy+11,181$21.40$239.27K112,416
Hoi Chun Lo
Chief Financial Officer
Aug 21, 2026Option exercise+32,736––566,013
Hoi Chun Lo
Chief Financial Officer
Aug 21, 2026Option exercise+45,815––566,013
Danny Sheng Wu Yeung
Chief Executive Officer, Director
Aug 20, 2026Other−49,912––87,735
Danny Sheng Wu Yeung
Chief Executive Officer, Director
Aug 20, 2026Option exercise+53,953––137,647
Danny Sheng Wu Yeung
Chief Executive Officer, Director
Aug 20, 2026Buy+7,500$18.31$137.33K95,235
Hudson Blake Leogrande
Director
Aug 4, 2026Option exercise+2,001––4,001
Hudson Blake Leogrande
Director
Jul 4, 2026Option exercise+2,000––2,000
Yin Pan Cheng
Director
Jun 15, 2026Option exercise+15,873––59,051
David Vanderveen
Director
Jun 15, 2026Option exercise+6,944––45,249

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
1M shares short
Days to cover
2.8
At 0M shares a day
Change since last report
-1.5%
From 1M shares
Short volume, 20 days
55.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Prenetics Global's stock actually held short. Settlement fails (shares not delivered on time) peaked at 25,305 shares on Aug 24, 2026 over the last 90 days.

See a number that looks wrong?